TRACY GEORGE, MD - EXECUTIVE DIRECTOR OF CLINICAL TRIALS AND PHARMADX AT ARUP LABORATORIES - PREVIEW 4
Update: 2020-06-05
Description
The diagnostics #industry is very fragmented, in terms of testing laboratories, test developers, and testing methodologies used.
Companion diagnostics testing for targeted therapies is still done by a variety of methodologies, including immunohistochemistry, FISH, RT-PCR, RNA expression analysis as well as next-generation sequencing, and others.
The advent of next-generation #sequencing, as many predicted, has not - as of yet - led to a more unified approach to testing. Why is this?
Companion diagnostics testing for targeted therapies is still done by a variety of methodologies, including immunohistochemistry, FISH, RT-PCR, RNA expression analysis as well as next-generation sequencing, and others.
The advent of next-generation #sequencing, as many predicted, has not - as of yet - led to a more unified approach to testing. Why is this?
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
